Study of MDX-1100 (Anti-CXCL10 Human Monoclonal Antibody) in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (RA)
Clinical trial NCT01017367 · COMPLETED
Trial details
- NCT number
- NCT01017367
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2009-01-01
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.